// App-Quantinova.ai

191 : LMTK3 is a novel regulator of oncogenic KIT in KIT-mutant cancers

Researchers

Presenter

  • Lillian R. Klug

Principal Investigators

  • Jeffery W. Tyner

  • Michael C. Heinrich

Medical Centers

  • Oregon Health and Science University, Portland, OR

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Gastrointestinal stromal tumor

  • Colorectal Cancer

  • Melanoma

  • Solid malignancies

Biomarkers

  • Hepatocyte growth factor receptor

  • Lemur tyrosine kinase-3

Drug/Treatment

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved